A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers
Clinical trial NCT06577298 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06577298
- Sponsor
- CanSino Biologics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-19
- Primary completion
- 2026-10-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.